Aclarion, Inc. (ACON)Healthcare | Health Information Services | Broomfield, United States | NasdaqCM
3.39 USD
+0.07
(2.108%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.43 +0.04 (1.180%) ⇧ (April 17, 2026, 5:32 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 12:11 a.m. EDT
Despite strong recent price momentum and significant volume jumps in scan volumes driven by Nociscan technology adoption, ACON remains a high-risk speculative hold. The short-term upside is tempered by heavy selling pressure (14.34x volume) and fundamentally unsustainable financials (negative earnings, negative operating cash flow, and negative adjusted predicted direction), while the company's inability to pay dividends renders it unsuitable for any income-focused strategy. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.177188 |
| AutoETS | 0.177193 |
| MSTL | 0.194931 |
| AutoTheta | 0.221646 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.10 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.180 |
| Excess Kurtosis | -1.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.142 |
| Market Cap | 7,737,238 |
| Forward P/E | -0.25 |
| Beta | 1.14 |
| Website | https://www.aclarion.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.57250947 |
| Address1 | 8,181 Arista Place |
| Address2 | Suite 100 |
| All Time High | 586,116.0 |
| All Time Low | 2.34 |
| Ask | 3.45 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 150,700 |
| Average Daily Volume3 Month | 99,746 |
| Average Volume | 99,746 |
| Average Volume10Days | 150,700 |
| Beta | 1.135 |
| Bid | 3.35 |
| Bid Size | 1 |
| Book Value | 15.023 |
| City | Broomfield |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.39 |
| Current Ratio | 14.806 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.43 |
| Day Low | 3.2007 |
| Display Name | Aclarion |
| Ebitda | -6,824,985 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.628 |
| Enterprise To Revenue | -56.629 |
| Enterprise Value | -4,288,551 |
| Eps Current Year | -4.37 |
| Eps Forward | -13.71 |
| Eps Trailing Twelve Months | -13.61 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.053 |
| Fifty Day Average Change | 0.33700013 |
| Fifty Day Average Change Percent | 0.11038327 |
| Fifty Two Week Change Percent | -57.250946 |
| Fifty Two Week High | 12.03 |
| Fifty Two Week High Change | -8.639999 |
| Fifty Two Week High Change Percent | -0.71820444 |
| Fifty Two Week Low | 2.34 |
| Fifty Two Week Low Change | 1.0500002 |
| Fifty Two Week Low Change Percent | 0.44871804 |
| Fifty Two Week Range | 2.34 - 12.03 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,650,634,200,000 |
| Float Shares | 2,038,294 |
| Forward Eps | -13.71 |
| Forward P E | -0.24726477 |
| Free Cashflow | -4,634,310 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.09016 |
| Gross Profits | 6,828 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10694 |
| Held Percent Institutions | 0.01311 |
| Implied Shares Outstanding | 2,282,371 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,743,120,000 |
| Last Split Factor | 1:27 |
| Long Business Summary | Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado. |
| Long Name | Aclarion, Inc. |
| Market | us_market |
| Market Cap | 7,737,238 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_108179695 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -7,240,312 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,828,532 |
| Number Of Analyst Opinions | 1 |
| Open | 3.33 |
| Operating Cashflow | -7,164,204 |
| Operating Margins | -107.85183 |
| Payout Ratio | 0.0 |
| Phone | 833 275 2266 |
| Post Market Change | 0.03999996 |
| Post Market Change Percent | 1.1799399 |
| Post Market Price | 3.43 |
| Post Market Time | 1,776,461,574 |
| Previous Close | 3.32 |
| Price Eps Current Year | -0.7757437 |
| Price Hint | 4 |
| Price To Book | 0.225654 |
| Price To Sales Trailing12 Months | 102.16873 |
| Profit Margins | 0.0 |
| Quick Ratio | 14.398 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0700002 |
| Regular Market Change Percent | 2.10844 |
| Regular Market Day High | 3.43 |
| Regular Market Day Low | 3.2007 |
| Regular Market Day Range | 3.2007 - 3.43 |
| Regular Market Open | 3.33 |
| Regular Market Previous Close | 3.32 |
| Regular Market Price | 3.39 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 68,960 |
| Return On Assets | -0.55809 |
| Return On Equity | -1.0479599 |
| Revenue Growth | 0.806 |
| Revenue Per Share | 0.142 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,282,371 |
| Shares Percent Shares Out | 0.0623 |
| Shares Short | 142,278 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 166,784 |
| Short Name | Aclarion, Inc. |
| Short Percent Of Float | 0.0623 |
| Short Ratio | 2.1 |
| Source Interval | 15 |
| State | CO |
| Symbol | ACON |
| Target High Price | 7.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 7.0 |
| Target Median Price | 7.0 |
| Total Cash | 12,025,789 |
| Total Cash Per Share | 5.269 |
| Total Debt | 0 |
| Total Revenue | 75,730 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -13.61 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.81075 |
| Two Hundred Day Average Change | -2.42075 |
| Two Hundred Day Average Change Percent | -0.41659853 |
| Type Disp | Equity |
| Volume | 68,960 |
| Website | https://www.aclarion.com |
| Zip | 80,021 |